These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 8061361

  • 1. Expression of early and late activation markers on peripheral blood T lymphocytes does not reliably reflect immune events in transplanted hearts.
    Loertscher R, Forbes RD, Halabi G, Lavery P, Quinn T.
    Clin Transplant; 1994 Jun; 8(3 Pt 1):230-8. PubMed ID: 8061361
    [Abstract] [Full Text] [Related]

  • 2. Identification of IL 2R+ T cells and macrophages within rejecting rat cardiac allografts, and comparison of the effects of treatment with anti-IL 2R monoclonal antibody or cyclosporin.
    Hancock WW, Lord RH, Colby AJ, Diamantstein T, Rickles FR, Dijkstra C, Hogg N, Tilney NL.
    J Immunol; 1987 Jan 01; 138(1):164-70. PubMed ID: 3097143
    [Abstract] [Full Text] [Related]

  • 3. Acute kidney graft rejection. A morphological and immunohistological study on "zero-hour" and follow-up biopsies with special emphasis on cellular infiltrates and adhesion molecules.
    Andersen CB, Ladefoged SD, Larsen S.
    APMIS; 1994 Jan 01; 102(1):23-37. PubMed ID: 7513171
    [Abstract] [Full Text] [Related]

  • 4. Additive value of immunologic monitoring to histologic grading of heart allograft biopsy specimens: implications for therapy.
    Fisher PE, Suciu-Foca N, Ho E, Michler RE, Rose EA, Mancini D.
    J Heart Lung Transplant; 1995 Jan 01; 14(6 Pt 1):1156-61. PubMed ID: 8719463
    [Abstract] [Full Text] [Related]

  • 5. [The coronary sinus as a source of activated T-lymphocytes in patients after orthotopic heart transplantation].
    Holzinger C, Zuckermann A, Schöllhammer A, Kopp C, Imhof M, Laufer G, Griesmacher A, Zwölfer W, Laczkovics A, Wolner E.
    Wien Klin Wochenschr; 1992 Jan 01; 104(24):748-52. PubMed ID: 1288018
    [Abstract] [Full Text] [Related]

  • 6. CD69 expression on peripheral CD8 T cells correlates with acute rejection in renal transplant recipients.
    Posselt AM, Vincenti F, Bedolli M, Lantz M, Roberts JP, Hirose R.
    Transplantation; 2003 Jul 15; 76(1):190-5. PubMed ID: 12865808
    [Abstract] [Full Text] [Related]

  • 7. Clinical relevance of in vitro propagation of activated lymphocytes from endomyocardial biopsy samples of pediatric heart transplant recipients.
    Webber SA, Bentlejewski C, Park A, Fricker FJ, Griffith C, Boyle GJ, Miller SA, Pham S, Murali S, Griffith BP, Duquesnoy R, Zeevi A.
    Pediatr Transplant; 1998 Aug 15; 2(3):200-5. PubMed ID: 10084743
    [Abstract] [Full Text] [Related]

  • 8. Semiquantitative measurement of cytokine messenger RNA in endomyocardium and peripheral blood mononuclear cells from human heart transplant recipients.
    Lagoo AS, George JF, Naftel DC, Griffin AK, Kirklin JK, Lagoo-Deenadayalan S, Hardy KJ, Savunen T, McGiffin DC.
    J Heart Lung Transplant; 1996 Feb 15; 15(2):206-17. PubMed ID: 8672525
    [Abstract] [Full Text] [Related]

  • 9. Inadequate immune regulatory function of CD4+CD25bright+FoxP3+ T cells in heart transplant patients who experience acute cellular rejection.
    Dijke IE, Korevaar SS, Caliskan K, Balk AH, Maat AP, Weimar W, Baan CC.
    Transplantation; 2009 Apr 27; 87(8):1191-200. PubMed ID: 19384166
    [Abstract] [Full Text] [Related]

  • 10. Cytokine expression and endothelial cell and lymphocyte activation in human cardiac allograft rejection: an immunohistochemical study of endomyocardial biopsy samples.
    Ruan XM, Qiao JH, Trento A, Czer LS, Blanche C, Fishbein MC.
    J Heart Lung Transplant; 1992 Apr 27; 11(6):1110-5. PubMed ID: 1360814
    [Abstract] [Full Text] [Related]

  • 11. Intragraft FOXP3 mRNA expression reflects antidonor immune reactivity in cardiac allograft patients.
    Dijke IE, Velthuis JH, Caliskan K, Korevaar SS, Maat AP, Zondervan PE, Balk AH, Weimar W, Baan CC.
    Transplantation; 2007 Jun 15; 83(11):1477-84. PubMed ID: 17565321
    [Abstract] [Full Text] [Related]

  • 12. Immunoglobulin M-to-immunoglobulin G anti-human leukocyte antigen class II antibody switching in cardiac transplant recipients is associated with an increased risk of cellular rejection and coronary artery disease.
    Lietz K, John R, Burke E, Schuster M, Rogers TB, Suciu-Foca N, Mancini D, Itescu S.
    Circulation; 2005 Oct 18; 112(16):2468-76. PubMed ID: 16230499
    [Abstract] [Full Text] [Related]

  • 13. Cell free serum interleukin-2 receptor levels after heart transplantation.
    McNally CM, Luckhurst E, Penny R.
    J Heart Lung Transplant; 1991 Oct 18; 10(5 Pt 1):769-74. PubMed ID: 1958685
    [Abstract] [Full Text] [Related]

  • 14. [Initial experiences in diagnosis of graft rejection following clinical heart transplantation. Detection of graft-directed activated T-cells].
    Werner M, Otto U, Keitel R, Klötzer B, Schürer KD, Walther J, Vogt S, Ambrosius H.
    Zentralbl Chir; 1990 Oct 18; 115(14):905-12. PubMed ID: 2238967
    [Abstract] [Full Text] [Related]

  • 15. Interleukin-2 receptor blockade in cardiac transplantation: influence of HLA-DR locus incompatibility on treatment efficacy.
    Lietz K, John R, Beniaminovitz A, Burke EM, Suciu-Foca N, Mancini DM, Edwards NM, Itescu S.
    Transplantation; 2003 Mar 27; 75(6):781-7. PubMed ID: 12660501
    [Abstract] [Full Text] [Related]

  • 16. Usefulness of T-cell phenotype characterization in endomyocardial biopsy fragments from human cardiac allografts.
    Higuchi ML, de Assis RV, Sambiase NV, Reis MM, Kalil J, Bocchi E, Fiorelli A, Stolf N, Bellotti G, Pileggi F.
    J Heart Lung Transplant; 1991 Mar 27; 10(2):235-42. PubMed ID: 1674430
    [Abstract] [Full Text] [Related]

  • 17. Myocardial HLA-G reliably indicates a low risk of acute cellular rejection in heart transplant recipients.
    Sheshgiri R, Rouas-Freiss N, Rao V, Butany J, Ramzy D, Krawice-Radanne I, Ross HJ, Carosella ED, Delgado DH.
    J Heart Lung Transplant; 2008 May 27; 27(5):522-7. PubMed ID: 18442718
    [Abstract] [Full Text] [Related]

  • 18. Expression of T cell activation antigen CD134 (OX40) has no predictive value for the occurrence or response to therapy of acute graft-versus-host disease in partial T cell-depleted bone marrow transplantation.
    Gadisseur AP, Gratama JW, Lamers C, van Esser JW, Bolhuis RL, Cornelissen JJ.
    Bone Marrow Transplant; 1999 May 27; 23(10):1013-7. PubMed ID: 10373067
    [Abstract] [Full Text] [Related]

  • 19. The intragraft gene activation of markers reflecting T-cell-activation and -cytotoxicity analyzed by quantitative RT-PCR in renal transplantation.
    Strehlau J, Pavlakis M, Lipman M, Maslinski W, Shapiro M, Strom TB.
    Clin Nephrol; 1996 Jul 27; 46(1):30-3. PubMed ID: 8832147
    [Abstract] [Full Text] [Related]

  • 20. Relationship of increased levels of circulating intercellular adhesion molecule 1 after heart transplantation to rejection: human leukocyte antigen mismatch and survival.
    Ballantyne CM, Mainolfi EA, Young JB, Windsor NT, Cocanougher B, Lawrence EC, Pollack MS, Entman ML, Rothlein R.
    J Heart Lung Transplant; 1994 Jul 27; 13(4):597-603. PubMed ID: 7947875
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.